AMZE vs GSK · rev $2.0M vs P/E 13, $103.31B cap
Amaze Holdings Inc (AMZE) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Amaze Holdings Inc (AMZE) is a beverages - wineries & distilleries company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported AMZE revenue for 2025-12-31 was $2.0M. Net income was -$55.2M. Revenue was up 557.8% from 2024-12-31 to 2025-12-31. AMZE currently screens at market cap $0.
GSK does not have a complete income-statement cache yet.
AMZE currently screens at market cap $0. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the AMZE and GSK stock pages for the full models.
Not investment advice.